Aratana Therapeutics

YTD

ALL

Why Robinhood?

You can watch PETX and buy or sell other stocks, ETFs, and their options commission-free!

About PETX

Aratana Therapeutics, Inc. engages in the development and commercialization of pet therapeutics. Its portfolio includes NOCITA, ENTYCE, and GALLIPRANT.

CEO

Craig A. Tooman, MBA

CEOCraig A. Tooman, MBA

Employees

—

Employees—

Headquarters

Leawood, Kansas

HeadquartersLeawood, Kansas

Founded

2010

Founded2010

Employees

—

Employees—

PETX Key Statistics

Market cap

—

Market cap—

Price-Earnings ratio

—

Price-Earnings ratio—

Dividend yield

—

Dividend yield—

Average volume

—

Average volume—

High today

—

High today—

Low today

—

Low today—

Open price

—

Open price—

Volume

0.00

Volume0.00

52 Week high

$7.16

52 Week high$7.16

52 Week low

$3.30

52 Week low$3.30

Stock Snapshot

As of today, Aratana Therapeutics(PETX) shares are valued at $4.92.

During the trading day, Aratana Therapeutics(PETX) stock saw an opening price of —, a peak of —, and a bottom of —.

Trading activity shows a volume of 0.

Over the past 52 weeks, Aratana Therapeutics(PETX) stock has traded between a high of $7.16 and a low of $3.30.